How is Antithrombin III deficiency diagnosed?

Antithrombin III deficiency is primarily diagnosed through specialized blood coagulation studies that measure the activity and antigen levels of the antithrombin protein. Because the condition is often asymptomatic until a thrombotic event occurs, diagnosis typically follows a personal or family history of unexplained blood clots (venous thromboembolism), confirming the diagnosis through functional and immunological assays.

How is Antithrombin III deficiency diagnosed?

The diagnostic process for Antithrombin III deficiency usually begins after a patient presents with a deep vein thrombosis (DVT) or pulmonary embolism (PE), particularly if the event is "unprovoked" or occurs at a young age. A physician will first order a standard coagulation screen, but since these tests (like PT or aPTT) are often normal in patients with Antithrombin III deficiency, the clinician must specifically request assays for antithrombin activity. The diagnostic process typically involves:

• Functional Antithrombin Activity Assay: This is the gold standard, measuring the ability of the protein to inhibit thrombin and factor Xa.


• Antigen Assay: This measures the actual amount of antithrombin protein present in the blood, helping to distinguish between Type I (low levels) and Type II (normal levels but low activity) deficiency.


• Genetic Testing: Once a deficiency is confirmed, molecular genetic testing (sequencing of the SERPINC1 gene) may be performed to identify the specific mutation, which is helpful for family screening.

Which specialists are involved in the diagnosis?

The diagnosis of Antithrombin III deficiency is usually managed by a hematologist, specifically one specializing in coagulation disorders or thrombosis. Because rare diseases often involve a "diagnostic odyssey," many patients find that their initial symptoms are dismissed by primary care physicians or emergency room staff. It is vital to seek a hematologist if you have a history of recurrent clots, as they possess the expertise to distinguish this condition from other thrombophilias.

What conditions might be confused with Antithrombin III deficiency?

In the differential diagnosis, physicians must rule out other causes of hypercoagulability. Antithrombin III deficiency is frequently confused with or evaluated alongside Factor V Leiden, Prothrombin G20210A mutation, and Protein C or Protein S deficiencies. Furthermore, acquired antithrombin deficiency—caused by liver disease, nephrotic syndrome, or disseminated intravascular coagulation (DIC)—must be ruled out through clinical evaluation to ensure the diagnosis is indeed the hereditary form of Antithrombin III deficiency.

Why is the diagnostic journey often so difficult?

We acknowledge that the path to a diagnosis of Antithrombin III deficiency can be incredibly frustrating. Many patients share stories of being told their symptoms were "anxiety-related" or simply "bad luck" before a definitive diagnosis was reached. Within the DiseaseMaps.org community, 42 people have connected to share their unique experiences, highlighting that you are not alone in this journey. Obtaining a diagnosis often requires persistent advocacy and, if necessary, seeking a second opinion from a center of excellence for hematology.

Next steps

• Consult a board-certified hematologist to interpret your coagulation profile.


• Request genetic counseling to understand the hereditary implications for your family members.


• Join the Antithrombin III deficiency community on DiseaseMaps.org to share experiences and coping strategies with others who understand the diagnosis.


• Maintain a detailed medical record of all clotting events, as this data is crucial for your long-term management plan.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider.

References

• National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD): Antithrombin deficiency.


• Orphanet: Antithrombin III deficiency.


• OMIM (Online Mendelian Inheritance in Man): Antithrombin III deficiency entry.


• National Blood Clot Alliance (NBCA): Information on inherited thrombophilias.